ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.

ArchiMed’s international team combines investment, medical, technological and operational experience. It works alongside management teams to accelerate their business growth, through internationalization, product and service range expansion as well as capacity extension, both organically and through acquisitions. Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large size healthcare companies throughout the world, with a combined value above five billion euros.

ArchiMed’s investment capacity currently exceeds one billion euros and potentially twice this amount when including its strategic investment partners.

Venture Capital

ArchiMed

Denis Ribon

Alice Bourgoin

Pascale Verrière

Sandrine Laporte

Cécile Pontier

André - Michel Ballester

Christoph Böhmer

Loïc Kubitza

Jean Yves Desmottes

Justin Bateman

Ludovic Alonzi

Solène Gallot

Magalie Rassed

Frédéric Cassan

Anaël Vindrier

Antoine Faguer

Eva Ravalison

Melvin Da Costa

Taryn Langlade

Alfred Gnonlonfoun

Stéphanie Du Ché

Baptiste Mélinon

Thierry Picard

Robin Filmer - Wilson

Christophe Berthoux

Brian Sheridan

Klaus Maleck

Vincent Guillaumot

The executive team at ArchiMed has a long history of experience in the field of finance. The team's experience ranges from working as a CFO at DECA CHIMIE to holding various other positions in the finance industry. In addition to this, the team also has a strong educational background, with members holding degrees from top universities.

CEO and Executive Team

Leadership Team

CEO and Executive Team

About

Team members

Other teams at ArchiMed

Leadership Team